The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease. A review

Neurosurgical Focus

Volumn 26, Issue 4, 2009, Pages

  Bacigaluppi, Susanna ^a,b   Dehdashti, Amir R ^a   Agid, Ronit ^a   Krings, Timo ^a   Tymianski, Michael ^a   Mikulis, David J ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Catheter angiography; Cerebrovascular reactivity; Computed tomography angiography; Diagnosis; Magnetic resonance imaging; Moyamoya disease; Neuroimaging modality

Indexed keywords

EID: 70349754171     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2009.01.focus08296     Document Type: Review

References (93)

1. Agid R, Lee SK, Willinsky RA, Farb RI, ter Brugge KG: Acute subarachnoid hemorrhage: using 64 slice multidetector CT angiography to "triage" patients' treatment. Neuroradiology 48:787-794, 2006.
2. Aoki S, Yoshikawa T, Hori M, Ishigame K, Nambu A, Kumagai H, et al: Two-dimensional thick-slice MR digital subtraction angiography for assessment of cerebrovascular occlusive diseases. Eur Radiol 10:1858-1864, 2000.
3. Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K: Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27:1750-1754, 1996.
4. Arita K, Kurisu K, Ohba S, Shibukawa M, Kiura H, Sakamoto S, et al: Endovascular treatment of basilar tip aneurysms associated with moyamoya disease. Neuroradiology 45:441-444, 2003.
5. Barnett HJM, Mohr JP, Stein BM, Yatsu F: Stroke: Pathophysiology, Diagnosis and Management, ed 3. Philadelphia: Churchill Livingstone, 1998, pp 229-234.
6. Bhattacharjee AK, Tamaki N, Minami H, Ehara K: Moyamoya disease associated with basilar tip aneurysm. J Clin Neurosci 6:268-271, 1999.
7. Bickler PE, Litt L, Banville DL, Severinghaus JW: Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol 65:422-427, 1988.
8. Chen ST, Liu YH, Hsu CY, Hogan EL, Ryu SJ: Moyamoya disease in Taiwan. Stroke 19:53-59, 1988.
9. Chiron C, Raynaud C, Mazière B, Zilbovicius M, Laflamme L, Masure MC, et al: Changes in regional cerebral blood flow during brain maturation in children and adolescents. J Nucl Med 33:696-703, 1992.
10. Coppens JR, Cantando JD, Abdulrauf SI: Minimally invasive superficial temporal artery to middle cerebral artery bypass through an enlarged bur hole: the use of computed tomography angiography neuronavigation in surgical planning. J Neurosurg 109:553-558, 2008.
11. da Costa LB, Valiante T, ter Brugge KG, Tymianski M: Anterior ethmoidal artery aneurysm and intracerebral hemorrhage. AJNR Am J Neuroradiol 27:1672-1674, 2006.
12. Derdeyn CP, Grubb RL Jr, Powers WJ: Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 53:251-259, 1999.
13. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, et al: Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain 125:595-607, 2002.
14. Devuyst G, Cals N, de Borchgrave V, Bara P, Vandooren M: Advantages of transcranial power duplex imaging after contrast injection to detect low flow in a moyamoya syndrome. Stroke 30:897-899, 1999.
15. Feygelman VM, Huda W, Peters KR: Effective dose equivalents to patients undergoing cerebral angiography. AJNR Am J Neuroradiol 13:845-849, 1992.
16. Fujiwara H, Momoshima S, Kuribayashi S: Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversionrecovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 55:224-230, 2005.
17. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 (2 Suppl): S238-S240, 1997.
18. Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, et al: Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology 239:232-237, 2006.
19. Gaa J, Weidauer S: Unusual differential diagnosis of leptomeningeal enhancement: moyamoya disease. J Neurol Neurosurg Psychiatry 75:1170, 2004.
20. Gotoh F, Shinohara Y: Role of carbonic anhydrase in chemical control and autoregulation of cerebral circulation. Int J Neurol 11:219-227, 1977.
21. Grabel JC, Levine M, Hollis P, Ragland R: Moyamoya-like disease associated with a lenticulostriate region aneurysm. Case report. J Neurosurg 70:802-803, 1989.
22. Grossmann WM: Koeberle: The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects. Cerebrovasc Dis 10:65-69, 2000.
23. Grubb RL Jr, Hernandez-Perez MJ, Raichle ME, Phelps ME: The effects of iodinated contrast agents on autoregulation of cerebral blood flow. Stroke 5:155-160, 1974.
24. Hallett RL, Fleischmann D: Tools of the trade for CTA: MDCT scanners and contrast medium injection protocols. Tech Vasc Interv Radiol 9:134-142, 2006.
25. Handa J, Nakano Y, Okuno T, Komuro H, Hojyo H, Handa H: Computerized tomography in Moyamoya syndrome. Surg Neurol 7:315-319, 1977.
26. Hans FJ, Reinges MH, Reipke P, Reinacher P, Krings T: Clinical applications of 2-D dynamic contrast-enhanced MR subtraction angiography in neurosurgery-preliminary results. Zentralbl Neurochir 66:170-179, 2005.
27. Harada M, Miyoshi H, Uno M, Okada T, Hisaoka S, Hori A, et al: Neuronal impairment of adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with tc-99m HM-PAO: a trial of clinical quantification of metabolites. J Magn Reson Imaging 10:124-129, 1999.
28. Hoffman HJ: Moyamoya disease and syndrome. Clin Neurol Neurosurg 99 (2 Suppl):S39-S44, 1997.
29. Højer-Pedersen E: Effect of acetazolamide on cerebral blood flow in subacute and chronic cerebrovascular disease. Stroke 18:887-891, 1987.
30. Honda M, Kitagawa N, Tsutsumi K, Morikawa M, Nagata I, Kaminogo M: Magnetic resonance angiography evaluation of external carotid artery tributaries in moyamoya disease. Surg Neurol 64:325-330, 2005.
31. Horn P, Vajkoczy P, Schmiedek P, Neff W: Evaluation of extracranial-intracranial arterial bypass function with magnetic resonance angiography. Neuroradiology 46:723-729, 2004.
32. Horn P, Vajkoczy P, Thomé C, Muench E, Schilling L, Schmiedek P: Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies. AJNR Am J Neuroradiol 22:1543-1549, 2001.
33. Huisman TA, Sorensen AG: Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol 14:59-72, 2004.
34. Ibaraki M, Miura S, Shimosegawa E, Sugawara S, Mizuta T, Ishikawa A, et al: Quantification of cerebral blood flow and oxygen metabolism with 3-dimensional PET and 15O: validation by comparison with 2-dimensional PET. J Nucl Med 49:50-59, 2008.
35. Ishikawa T, Kuroda S, Nakayama N, Terae S, Kudou K, Iwasaki Y: Prevalence of asymptomatic microbleeds in patients with moyamoya disease. Neurol Med Chir (Tokyo) 45:495- 500, 2005.
36. Iwama T, Todaka T, Hashimoto N: Direct surgery for major artery aneurysm associated with moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl):S191-S193, 1997.
37. Kang KH, Kim HS, Kim SY: Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation. AJNR Am J Neuroradiol 29:1487-1493, 2008.
38. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K: Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir (Wien) 138:1287-1294, 1996.
39. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, et al: Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102:470-475, 2005.
40. Kimura H, Oka K, Ikeda K, Yamamoto M, Tomonaga M: The clinical significance of cerebral veins in moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl):S90-S95, 1997.
41. Komiyama M, Nakajima H, Nishikawa M, Yasui T, Kitano S, Sakamoto H: Leptomeningeal contrast enhancement in moyamoya: its potential role in postoperative assessment of circulation through the bypass. Neuroradiology 43:17-23, 2001.
42. Krings T, Hans F: New developments in MRA: time-resolved MRA. Neuroradiology 46 (2 Suppl):S214-S222, 2004.
43. Kuroda S, Houkin K: Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056-1066, 2008.
44. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y: Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36:2148-2153, 2005.
45. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Ikezaki K, et al: Cerebral hemodynamics and metabolism in moyamoya disease-a positron emission tomography study. Clin Neurol Neurosurg 99 (2 Suppl):S74-S78, 1997.
46. Lee JK, Lee JH, Kim SH, Lee MC: Distal anterior choroidal artery aneurysm in a patient with moyamoya disease: case report. Neurosurgery 48:222-225, 2001.
47. Lee YS, Jung KH, Roh JK: Diagnosis of moyamoya disease with transcranial Doppler sonography: correlation study with magnetic resonance angiography. J Neuroimaging 14:319- 323, 2004.
48. Leinsinger G, Piepgras A, Einhäupl K, Schmiedek P, Kirsch CM: Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT. AJNR Am J Neuroradiol 15:1327- 1332, 1994.
49. Maeda M, Tsuchida C: "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 20:1836-1838, 1999.
50. Maeda M, Yagishita A, Yamamoto T, Sakuma H, Takeda K: Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: a spectrum of central nervous system diseases. Eur Radiol 13 (4 Suppl):L192-L201, 2003.
51. Mandell DM, Han JS, Poublanc J, Crawley AP, Stainsby JA, Fisher JA, et al: Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke 39:2021-2028, 2008.
52. Marushima A, Yanaka K, Matsuki T, Kojima H, Nose T: Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease. J Clin Neurosci 13:146-149, 2006.
53. McAuley DJ, Poskitt K, Steinbok P: Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. Neurosurgery 55:327-332, 2004.
54. Mikulis DJ, Krolczyk G, Desal H, Logan W, Deveber G, Dirks P, et al: Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. J Neurosurg 103:347-355, 2005.
55. Morgenstern C, Griewing B, Müller-Esch G, Zeller JA, Kessler C: Transcranial power-mode duplex ultrasound in two patients with moyamoya syndrome. J Neuroimaging 7:190-192, 1997.
56. Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, et al: Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol 43:574-579, 2008.
57. Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, et al: Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34:90-95, 2003.
58. Murai Y, Takagi R, Ikeda Y, Yamamoto Y, Teramoto A: Three-dimensional computerized tomography angiography in patients with hyperacute intracerebral hemorrhage. J Neurosurg 91:424-431, 1999.
59. Murphy MJ: Progressive vascular changes in Moyamoya syndrome. Stroke 11:656-658, 1980.
60. Nakagawara J, Takeda R, Suematsu K, Nakamura J: Quantification of regional cerebral blood flow and vascular reserve in childhood moyamoya disease using [123I]IMP-ARG method. Clin Neurol Neurosurg 99 (2 Suppl):S96-S99, 1997.
61. Nakashima T, Nakayama N, Furuichi M, Kokuzawa J, Murakawa T, Sakai N: Arteriovenous malformation in association with moyamoya disease. Report of two cases. Neurosurg Focus 5(5):E6, 1998.
62. Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, et al: Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 76:663-669, 2005.
63. Nariai T, Senda M, Ishii K, Wakabayashi S, Yokota T, Toyama H, et al: Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study. Stroke 29:1281-1292, 1998.
64. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M: Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol 16:563-570, 1995.
65. Nariai T, Suzuki R, Matsushima Y, Ichimura K, Hirakawa K, Ishii K, et al: Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke 25:1014-1021, 1994.
66. Neff KW, Horn P, Schmiedek P, Düber C, Dinter DJ: 2D cine phase-contrast MRI for volume flow evaluation of the brain-supplying circulation in moyamoya disease. AJR Am J Roentgenol 187:W107-W115, 2006.
67. Ogawa S, Clauss M, Kuwabara K, Shreeniwas R, Butura C, Koga S, et al: Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc Natl Acad Sci U S A 88:9897-9901, 1991.
68. Ohta T, Tanaka H, Kuroiwa T: Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report. Neurosurgery 37:1009-1012, 1995.
69. Oshima H, Katayama Y, Hirayama T: Intracerebral steal phenomenon associated with global hyperemia in moyamoya disease during revascularization surgery. J Neurosurg 92:949- 954, 2000.
70. Perren F, Horn P, Vajkoczy P, Schmiedek P, Meairs S: Power Doppler imaging in detection of surgically induced indirect neoangiogenesis in adult moyamoya disease. J Neurosurg 103:869-872, 2005.
71. Rostrup E, Larsson HB, Toft PB, Garde K, Thomsen C, Ring P, et al: Functional MRI of CO2 induced increase in cerebral perfusion. NMR Biomed 7:29-34, 1994.
72. Ruan LT, Duan YY, Cao TS, Zhuang L, Huang L: Color and power Doppler sonography of extracranial and intracranial arteries in Moyamoya disease. J Clin Ultrasound 34:60-69, 2006.
73. Sakamoto S, Ohba S, Shibukawa M, Kiura Y, Arita K, Kurisu K: CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization. Acta Neurochir (Wien) 148:77-81, 2006.
74. Sato S, Shirane R, Maruoka S, Yoshimoto T: Evaluation of neuronal loss in adult moyamoya disease by 123I-iomazenil SPECT. Surg Neurol 51:158-163, 1999.
75. Schreiber WG, Gückel F, Stritzke P, Schmiedek P, Schwartz A, Brix G: Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 18:1143-1156, 1998.
76. Shimizu H, Shirane R, Fujiwara S, Takahashi A, Yoshimoto T: Proton magnetic resonance spectroscopy in children with moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl): S64-S67, 1997.
77. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288-299, 1969.
78. Takahashi M, Miyauchi T, Kowada M: Computed tomography of Moyamoya disease: demonstration of occluded arteries and collateral vessels as important diagnostic signs. Radiology 134:671-676, 1980.
79. Takase K, Kashihara M, Hashimoto T: Transcranial Doppler ultrasonography in patients with moyamoya disease. Clin Neurol Neurosurg 99 (2 Suppl):S101-S105, 1997.
80. Takeuchi S, Kobajashi K, Tuchida T, Imamura H, Tanaka R, Ito J: Computed tomography in Moyamoya disease. J Comput Assist Tomogr 6:24-32, 1982.
81. Tosaka M, Sato N, Fujimaki H, Tanaka Y, Kagoshima K, Takahashi A, et al: Diffuse pachymeningeal hyperintensity and subdural effusion/hematoma detected by fluid-attenuated inversion recovery MR imaging in patients with spontaneous intracranial hypotension. AJNR Am J Neuroradiol 29:1164-1170, 2008.
82. Touho H, Karasawa J, Ohnishi H: Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke 27:282-289, 1996.
83. van Straten M, Venema HW, Majoie CB, Freling NJ, Grimbergen CA, den Heeten GJ: Image quality of multisection CT of the brain: thickly collimated sequential scanning versus thinly collimated spiral scanning with image combining. AJNR Am J Neuroradiol 28:421-427, 2007.
84. Vesely A, Sasano H, Volgyesi G, Somogyi R, Tesler J, Fedorko L, et al: MRI mapping of cerebrovascular reactivity using square wave changes in end-tidal PCO2. Magn Reson Med 45:1011-1013, 2001.
85. Vörös E, Kiss M, Hankó J, Nagy E: Moyamoya with arterial anomalies: relevance to pathogenesis. Neuroradiology 39:852-856, 1997.
86. Warren DJ, Hoggard N, Walton L, Radatz MW, Kemeny AA, Forster DM, et al: Cerebral arteriovenous malformations: comparison of novel magnetic resonance angiographic techniques and conventional catheter angiography. Neurosurgery 61 (1 Suppl):187-196, 2007.
87. Wintermark M, Maeder P, Verdun FR, Thiran JP, Valley JF, Schnyder P, et al: Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. AJNR Am J Neuroradiol 21:1881-1884, 2000.
88. Wintermark M, Sesay M, Barbier E, Borbély K, Dillon WP, Eastwood JD, et al: Comparative overview of brain perfusion imaging techniques. Stroke 36:e83-e99, 2005.
89. Wintermark M, Sincic R, Sridhar D, Chien JD: Cerebral perfusion CT: technique and clinical applications. J Neuroradiol 35:253-260, 2008.
90. Yamada I, Nakagawa T, Matsushima Y, Shibuya H: High-resolution turbo magnetic resonance angiography for diagnosis of Moyamoya disease. Stroke 32:1825-1831, 2001.
91. Yang CY, Chen YF, Lee CW, Huang A, Shen Y, Wei C, et al: Multiphase CT angiography versus single-phase CT angiography: comparison of image quality and radiation dose. AJNR Am J Neuroradiol 29:1288-1295, 2008.
92. Yang SH, Li B, Wang CC, Zhao JZ: Angiographic study of moyamoya disease and histological study in the external carotid artery system. Clin Neurol Neurosurg 99 (2 Suppl): S61-S63, 1997.
93. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW: Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 79:483-489, 1993.